General Information of Drug (ID: DME7B2O)

Drug Name
SER-401
Indication
Disease Entry ICD 11 Status REF
Metastatic melanoma 2E2Z Phase 1 [1]
Drug Type
Live biotherapeutic product
Cross-matching ID
TTD ID
DT2B6G

References

1 ClinicalTrials.gov (NCT03817125) Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW). U.S. National Institutes of Health.